Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/30/2025 5:19:16 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 2131
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
cardamine
07/16/2025 10:18:30 AM
Or in the words of the great Denzel,
(3)
KenChowder
07/16/2025 9:37:55 AM
To be honest, to a layperson like
(13)
Katangolo
07/16/2025 9:26:47 AM
Hes saying we are onto something
(2)
KenChowder
07/16/2025 9:15:42 AM
Good news, Riz. But what is My saying?
(2)
Riztheinvestor
07/16/2025 9:00:39 AM
You are brilliant
(1)
HouseofCards
07/16/2025 12:39:26 AM
The fiscal year end was May
cardamine
07/16/2025 12:26:38 AM
Looks like that 5-year sample deadline
(3)
My69z
07/16/2025 12:05:37 AM
NCT02175680 04-16-2014 HIV Patient
MJS719
07/15/2025 10:34:36 PM
And apparently this group of
(6)
Figgs
07/15/2025 10:15:41 PM
I am with you on this one ER! If we
(3)
MJS719
07/15/2025 10:11:34 PM
Well, at the very least we know that
(12)
My69z
07/15/2025 10:11:15 PM
Page 10 of the trial paper Nov. 19th,
My69z
07/15/2025 10:08:38 PM
12-07-2020 --- NCT02859961 Enrollment
(8)
Shelly2626
07/15/2025 7:25:58 PM
Yep Agreed GLTA Longs
MGK_2
07/15/2025 6:51:35 PM
just ignore that last post: when is
(3)
MidnightRider
07/15/2025 5:39:32 PM
Are we operating by a Fiscal or
My69z
07/15/2025 3:05:09 PM
Dr. J brkfst news for u: I had my
(1)
Evil Rabbit
07/15/2025 3:03:31 PM
I'd take a PR around what Dr. J. had
(22)
Mr3Putt
07/15/2025 2:54:19 PM
Imagine news I try man, I try. Getting
(9)
My69z
07/15/2025 2:40:19 PM
Imagine news of LL upregulated CD4+ T
(3)
My69z
07/15/2025 2:23:44 PM
FDA regulations, reserve samples from
(2)
My69z
07/15/2025 9:12:38 AM
Kat...don't know the legal time limit
Katangolo
07/15/2025 9:02:03 AM
I would sure hope so. Thats how I
(3)
My69z
07/15/2025 8:11:27 AM
5 in Hiv rolled over in the trial & @
(2)
My69z
07/15/2025 1:02:37 AM
Date: 26-May-2021 Protocol Number:
(7)
brentie
07/14/2025 4:16:50 PM
"Our understanding of the genetics
(6)
Riztheinvestor
07/14/2025 11:43:44 AM
We have a AI partner with identity
(2)
Figgs
07/13/2025 11:04:48 PM
I was trying to put a positive spin on
(2)
dfwl28
07/13/2025 7:58:30 PM
https://youtu.be/GIUu239FWMg
(8)
sean007
07/13/2025 7:46:15 PM
Here's another mystery...where's the $2
(3)
sean007
07/13/2025 6:31:47 PM
I'm educated on the same level with
(3)
Katangolo
07/13/2025 6:20:59 PM
OK, Im picking up the jacket and
(7)
Riztheinvestor
07/13/2025 5:22:38 PM
Will AI cut review times? The truth
(6)
enemyofpluto
07/13/2025 4:40:59 PM
3500 job cuts (by doge, mush and trump)
(17)
ohm20
07/13/2025 4:35:09 PM
Thank you for verifying. Point 2) is an
(15)
sean007
07/13/2025 4:27:05 PM
Wouldn't AI help to ramp the speed up
(2)
chazzledazzle
07/13/2025 4:18:05 PM
The one problem with this will be
(4)
Katangolo
07/13/2025 4:16:13 PM
Wow. Thats big. Thanks again for
ohm20
07/13/2025 4:14:39 PM
Amid the FDA chaos there is a new
(8)
ohm20
07/13/2025 4:08:26 PM
The chemo causes indiscriminate DNA
(12)
Katangolo
07/13/2025 4:00:52 PM
Thank you for verifying. Point 2) is an
(4)
Riztheinvestor
07/13/2025 3:47:43 PM
1. Chemotherapys Broad Damage:
(3)
Figgs
07/13/2025 3:45:44 PM
Amid the FDA chaos there is a new
(6)
Katangolo
07/13/2025 3:33:19 PM
Awesome. Thank you for that. As a
ohm20
07/13/2025 3:29:55 PM
I think BPG's drug would add little to
(6)
Katangolo
07/13/2025 3:28:19 PM
Then we have this New MOA which
(1)
Katangolo
07/13/2025 3:26:10 PM
BPG thought that it couldnt hurt and
(2)
Katangolo
07/13/2025 3:22:01 PM
Thanks again, Ohm. So does this mean
ohm20
07/13/2025 2:51:36 PM
the new MOA where LL primes cold
(9)
Katangolo
07/13/2025 2:24:45 PM
All of this is true. I think what I was
(3)
Newer
Older
Recent Articles
Chevron Prepares to Announce Q3 Financial Results Soon
Exciting Tesla Cybercab Prototype: Steering Wheel Surfaces
China Leads the Way in Urban Health amidst Climate Challenges
Zoomlion's Vision for Sustainable Smart Cities Worldwide
Crédit Agricole S.A. Completes Share Repurchase Program Successfully
Fresnillo Makes Strategic Move to Acquire Probe Gold
Projected Growth of Genomics Data Analysis Market to 2034
Nanobiotix Secures Up to $71 Million in Innovative Funding
Exciting Launch of $PRDT Token Promises Revenue Sharing Rewards
Michael Burry's Caution: Avoiding Market Bubbles in 2025
Rep. Marjorie Taylor Greene Increases Investment in Tech Stocks
AB Artea Bankas Receives Updated Capital Requirements from ECB
Mohamed El-Erian Analyzes AI Market: Cautiously Optimistic
Bekaert's Share Buyback Program and Liquidity Actions Explained
Sidetrade Partners with NX to Enhance CFO Agility and Growth
Top Stock Performers: Insights on Major Market Movers
Facephi Shows Strong Financial Performance and Future Growth
Kalmar Reports Strong Q3 2025: Profitability and Success in Services
Loomis Achieves Remarkable Performance in Recent Quarter
Analyzing Investor Sentiment: Nasdaq's Recent Performance Trends
Exxon Mobil's Q3 Earnings Preview: Analyst Predictions and Insights
DXS International's Annual Report: Key Insights and Financials
Digitalist Group's Third Quarter Review Highlights 2025 Results
Strong Q3 Results Highlight Growth and Stability for WEHB
NB Private Equity Partners Effectively Executes Share Buyback
ICG Enterprise Trust plc Makes Strategic Share Buyback Move
Understanding the Voting Rights of Northern Venture Trust PLC
Nanobiotix Partners with Healthcare Royalty for $71 Million Deal
Fresnillo Enters Agreement to Purchase Probe Gold for C$780M
Understanding Voting Rights at Northern 2 VCT PLC
Notable Growth for INVL Technology in 2025 Financials
Understanding the Latest Net Asset Value of INVL Technology
Nxera Pharma's Vision Unveiled at Upcoming London Healthcare Conference
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
Tetragon Financial Group Reveals September 2025 Insights
Bioretec Ltd Updates Financial Report Details for 2025
Loomis Reports Robust Performance in Q3 2025 with Growth
Investments from Optiver and Qube Strengthen McKay Brothers
Strategic Investments by Optiver and QRT Propel McKay Brothers
Mycenax Partners with RIN Institute to Transform ADC Technology
Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
Corbus Pharmaceuticals Moves Forward with Public Offering
S&P 500 Achieves Historic Winning Streak and Market Insights
Key Challenges Highlighted by Michael Saylor for Growth Strategy
Ecer.com Launches Innovative AI Marketplace Strategy for Trade
Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
Danske Bank Sees Positive Trends and Growth for 2025
Sampo plc's Latest Share Buyback Program and Results
Exciting Developments in Kudu Well Appraisal by BW Energy